Banner Image

Test Directory

FISH, Myeloid Neoplasms, MECOM (EVI1), 3q26.2

Test Summary

Disruption of the human entropic virus integration site (EVI1 or MECOM) gene located at chromosome band 3q26.2 is associated with myeloid neoplasms and is indicative of a poor prognosis. EVI1 rearrangements are especially frequent in myeloid blast crisis that evolves through tyrosine kinase inhibitors. It has been associated with dysplasia of megakaryocytes and alters differentiation of other myeloid cells. Associated rearrangements include inv(3)(q21q26), t(3;3)q21;q26), t(3;21)(q26;q22) and t(3;12)(q26;p13).

Aliases

  • N/A

Specimen Collection

Special Instructions

N/A

Preferred Specimen

3 mL bone marrow or 5 mL whole blood collected in a sodium heparin (green-top) tube

Minimum Volume

1 mL bone marrow • 3 mL whole blood

Instructions

1-3 mL bone marrow in a sodium heparin (green-top) tube is preferred. Bone marrow or peripheral blood in sodium heparin tube (green top, dark/royal blue, tan top) are acceptable. Ship at room temperature.

If results are not possible, the test order may be canceled and replaced with a Cytogenetics Communication.

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Room temperature

Specimen Stability

  • Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. Do not reject.

Limitations

N/A

Other Acceptable Specimens

Bone marrow collected in: sodium heparin lead-free (tan-top), or sodium heparin (royal blue-top) tube
Whole blood (not NY approved) collected in: sodium heparin (green-top) tube, sodium heparin (royal blue-top) tube, or sodium heparin lead-free (tan-top) tube

Unacceptable Specimens

N/A

Order Code

EVI1

EPIC (Premier) Code

LAB5355

Includes

N/A

CPT Code

  • 88271 (x3)
  • 88275 - Please note: Whole blood is not New York approved for patient testing.

Billing Code

  • 670286
  • 670287

CPT Statement

Methodology

Fluorescence In Situ Hybridization (FISH)

FDA Status

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Physician Attestation of Informed Consent

N/A

Testing Laboratory

Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly VA, 20153

Department

Reference Testing

Reference Range

See Laboratory Report

Setup Schedule / Expected Turnaround Time

Daily; Report available: 6 days

Specimen Collection

Special Instructions

N/A

Preferred Specimen

3 mL bone marrow or 5 mL whole blood collected in a sodium heparin (green-top) tube

Minimum Volume

1 mL bone marrow • 3 mL whole blood

Instructions

1-3 mL bone marrow in a sodium heparin (green-top) tube is preferred. Bone marrow or peripheral blood in sodium heparin tube (green top, dark/royal blue, tan top) are acceptable. Ship at room temperature.

If results are not possible, the test order may be canceled and replaced with a Cytogenetics Communication.

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Room temperature

Specimen Stability

  • Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. Do not reject.

Limitations

N/A

Other Acceptable Specimens

Bone marrow collected in: sodium heparin lead-free (tan-top), or sodium heparin (royal blue-top) tube
Whole blood (not NY approved) collected in: sodium heparin (green-top) tube, sodium heparin (royal blue-top) tube, or sodium heparin lead-free (tan-top) tube

Unacceptable Specimens

N/A

Billing

CPT Code

  • 88271 (x3)
  • 88275 - Please note: Whole blood is not New York approved for patient testing.

Billing Code

  • 670286
  • 670287

CPT Statement

Result Information

Methodology

Fluorescence In Situ Hybridization (FISH)

Testing Laboratory

N/A

Reference Range

See Laboratory Report

Setup Schedule / Expected Turnaround Time

Daily; Report available: 6 days